<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT932-1800</title>
	</head>
	<body>
		<main>
			<p>930622 FT  22 JUN 93 / UK Company News: Amersham Intl Amersham International, the health science group, has received US marketing approval for Metastron, its injectable radiopharmaceutical, from the Food and Drug Administration. Earlier this year, Amersham joined with Zeneca to co-promote the drug, which helps control pain of secondary cancer that has spread to the bone.</p>
		</main>
</body></html>
            